1-170160529-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000439373.3(NTMT2):c.166G>A(p.Ala56Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000978 in 1,534,056 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000439373.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NTMT2 | NM_001136107.2 | c.166G>A | p.Ala56Thr | missense_variant | 2/4 | ENST00000439373.3 | NP_001129579.1 | |
NTMT2 | XM_011509232.3 | c.-30G>A | 5_prime_UTR_variant | 3/5 | XP_011507534.1 | |||
NTMT2 | XM_011509233.3 | c.-30G>A | 5_prime_UTR_variant | 4/6 | XP_011507535.1 | |||
NTMT2 | XM_011509234.3 | c.-30G>A | 5_prime_UTR_variant | 3/5 | XP_011507536.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NTMT2 | ENST00000439373.3 | c.166G>A | p.Ala56Thr | missense_variant | 2/4 | 1 | NM_001136107.2 | ENSP00000408058 | P1 | |
NTMT2 | ENST00000367764.3 | n.161G>A | non_coding_transcript_exon_variant | 2/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152114Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000141 AC: 2AN: 141578Hom.: 0 AF XY: 0.0000268 AC XY: 2AN XY: 74534
GnomAD4 exome AF: 0.00000941 AC: 13AN: 1381942Hom.: 0 Cov.: 30 AF XY: 0.0000117 AC XY: 8AN XY: 681046
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152114Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 02, 2024 | The c.166G>A (p.A56T) alteration is located in exon 2 (coding exon 2) of the METTL11B gene. This alteration results from a G to A substitution at nucleotide position 166, causing the alanine (A) at amino acid position 56 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at